(Q34722813)

4 August 2017

1 reference

title

Human herpes virus 6 and multiple sclerosis (English)

1 reference

4 August 2017

0 references

Moore FG

1

1 reference

4 August 2017

Wolfson C

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Acta Neurologica Scandinavica

4 August 2017

published in

1 reference

4 August 2017

volume

106

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

63-83

1 reference

The virology of demyelinating diseases

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Herpesviruses--Immune Escape Artists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Fall in human herpesvirus 6 seropositivity with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Central nervous system complications in human herpesvirus-6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus-6 infection in children. A prospective study of complications and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus 6 infection in normal human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Concepts of viral pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Case-control studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Multiple sclerosis and varicella zoster virus infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

A potential role for human herpesvirus type 6 in nervous system disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

The association of the human herpesvirus-6 and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Prevalence of IgM Antibodies to Human Herpesvirus 6 Early Antigen (p41/38) in Patients with Chronic Fatigue Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Infrequent detection of human herpesvirus 6 DNA in peripheral blood mononuclear cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpes virus 6 and human herpes virus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Neuroinvasion and persistence of human herpesvirus 6 in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

MS epidemiology world wide. One view of current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Multiple sclerosis and antecedent infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Epidemiology of multiple sclerosis: a critical overview.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Evidence for multiple sclerosis as an infectious disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Viruses and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

1 reference

7 January 2021

Intrathecal synthesis of antibodies to human herpesvirus 6 early antigen in patients with meningitis/encephalitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Age prevalence of antibody to human herpesvirus 6

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Chronic myelopathy associated with human herpesvirus-6

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Human herpesvirus 6 is associated with focal encephalitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

More mayhem from molecular mimics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Lymphoproliferative responses to human herpesvirus-6 variant A and variant B in healthy adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Newest human herpesvirus (HHV-6) in the Guillain-Barré syndrome and other neurological diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Standardization and quality control of PCR analyses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

HHV-6 and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Leukotropic herpesviruses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

HHV-6 and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01251.X

7 January 2021

10.1034/J.1600-0404.2002.01251.X

Identifiers

DOI

1 reference

4 August 2017

1 reference